8-K 1 f8k031908.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

_________________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported):  March 19, 2008

 

OPHTHALMIC IMAGING SYSTEMS  

(Exact Name of Registrant as Specified in its Charter)

 

 

CALIFORNIA

1-11140

94-3035367

(State or Other Jurisdiction of

(Commission File Number)

(I.R.S. Employer Identification No.)

Incorporation)

 

 

 


221 Lathrop Way, Suite I
Sacramento, California

 

95815

 

(Address of Principal Executive)

 

(Zip Code)

 

 

(Registrant’s telephone number, including area code): (916) 646-2020

 

                                                             Not Applicable                                                              

(Former Name or Former Address, if Changed Since Last Report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

Item 2.02

 

Results of Operations and Financial Condition
 

        On March 19, 2008, Ophthalmic Imaging Systems (the “Registrant”) issued a press release announcing financial results for the fiscal quarter and year ended December 31, 2007, attached hereto as Exhibit 99.1.

 

Item 7.01.

 

Regulation FD Disclosure

 


On March 19, 2008, the Registrant issued the press release attached hereto as Exhibit 99.1.

  

  

Item 9.01.

 

  

  

Financial Statements and Exhibits.

 

(c)

 

Exhibits

 

 

Exhibit Number

 

Description

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: March 21, 2008

OPHTHALMIC IMAGING SYSTEMS


By:    /s/ Ariel Shenhar                              
Name: Ariel Shenhar
Title:   Chief Financial Officer